A rheumatoid arthritis diagnosis usually starts quietly. You get a pill bottle and a plan to reassess in a few months. Then the plan changes, and suddenly your rheumatologist is mentioning infusions. The quick answer: treatment moves to infusion therapy when methotrexate and other oral DMARDs no longer control moderate to high disease activity. This usually happens after a maximized methotrexate trial. Sometimes a biologic is added by injection first. Here is how that progression actually works, and what it means once infusion becomes the next step.
Step one: most RA treatment starts with methotrexate alone
Current American College of Rheumatology guidelines recommend methotrexate as first-line treatment. This applies to most patients with moderate to high disease activity. Rheumatologists typically push the dose as high as a patient can tolerate before adding anything else. Methotrexate works for many people. It is inexpensive, well studied, and taken as a pill or injection at home. If your joints have calmed down on methotrexate alone, infusion therapy is not on the table yet. It shouldn’t be.
Step two: when methotrexate stalls, biologics enter the picture
Some patients maximize methotrexate and still have active, swollen joints. This is the point where biologic DMARDs usually come up in conversation. Biologics work differently than methotrexate. They target specific parts of the immune system responsible for RA’s inflammation. Many biologics start as an injection you give yourself at home, like adalimumab or etanercept. Others, like infliximab, tocilizumab, and rituximab, are only available as an infusion given at a clinic. The choice between an injectable and an infused biologic depends on several factors. Your rheumatologist weighs which specific drug fits your case, your antibody status, and other health conditions.
Step three: infusion becomes the practical choice
Infusion therapy usually enters the conversation for a few clear reasons. Your rheumatologist may prefer an infused biologic because of how your specific disease markers respond to it. You may struggle with self-injections due to needle anxiety or dexterity issues from active joint disease. Your insurance may require step therapy, meaning you try and fail certain medications before an infused option gets approved. Some infused biologics also allow longer gaps between treatments. That appeals to patients who want fewer decisions to manage week to week.
What actually happens at your first infusion appointment
Your rheumatologist sends a referral specifying your medication and dosage. From there, a dedicated infusion center verifies your insurance and handles prior authorization on your behalf. At your appointment, a nurse starts an IV and monitors you throughout the infusion. The visit can run anywhere from 30 minutes to several hours, depending on the drug. Most patients return every four to eight weeks, though the exact schedule depends on which biologic you’re prescribed. You can read more about rheumatoid arthritis and how infusion therapy fits into treatment on our conditions page.
This is not a sign your RA has gotten worse
Patients often hear “infusion” and assume it means their disease has spiraled. That is rarely the full picture. Moving to a biologic, whether by infusion or injection, usually means your care team is adjusting strategy. It is rarely a reaction to a crisis. Rheumatoid arthritis treatment follows a “treat to target” approach. Medication gets adjusted until disease activity drops to a defined low level, then holds there. Infusion therapy is simply one tool for reaching that target when oral medication alone falls short.
Frequently Asked Questions About Rheumatoid Arthritis Treatment
How do I know if my RA treatment should move to a biologic? Your rheumatologist tracks disease activity through joint counts, inflammation markers from bloodwork like CRP and ESR, and your reported symptoms. If these stay elevated despite a maximized methotrexate dose, a biologic typically becomes the next step, whether injected or infused.
Are RA infusions permanent once you start them? Not necessarily. Some patients who reach sustained low disease activity or remission can taper their biologic dose under close supervision. This decision is made carefully with your rheumatologist and depends on how stable your disease has been.
Do RA infusions work faster than oral medication? Some infused biologics, like infliximab, can show improvement within weeks, faster than methotrexate’s typical two- to three-month onset. Response time still varies by drug and by patient, so your rheumatologist will track your progress closely after starting.
Wondering if your RA treatment plan is heading toward infusion therapy? Contact Infusion Specialists to ask what to expect. Learn more about our team, browse our full list of treatments, or read reviews from our patients on Google before your first visit.